Skip to main content

Neuroone Medical Technologies Corp

NMTC
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001500198

In the last 90 days, Neuroone Medical Technologies Corp insiders filed 1 open-market purchase and 0 sales; 26 institutions reported holding it in 13F filings for Q2 2026, worth $6.21M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Neuroone Medical Technologies Corp changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of NMTC: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders2116−5
Shares1.27M1.51M+240.0K (+18.9%)
Value$1.53M$2.44M+$907.7K (+59.4%)

New holders (3)

Institutions that held Neuroone Medical Technologies Corp at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to NMTC in Q1 2023
InstitutionSharesValue% of portfolio
SG Americas Securities, LLC57,219$92.0K0.00%
Princeton Global Asset Management LLC16,833$27.1K0.01%
FNY Investment Advisers, LLC2,000$3.00K0.00%

Sold out (8)

Institutions that held Neuroone Medical Technologies Corp at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of NMTC in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Susquehanna International Group, LLP85,926$103.1K
Citadel Advisors LLC36,098$43.3K
Jane Street Group, LLC21,157$25.4K
Virtu Financial LLC14,939$18.0K
Morgan Stanley2,699$3.24K
Belpointe Asset Management LLC682$818
Money Concepts Capital Corp113$136
Bank of America Corp34$40